J Mazieres

Summary

Country: France

Publications

  1. ncbi request reprint [Nodular bronchioloalveolar carcinoma at early stage]
    J Mazieres
    Service de Pneumologie, CHR Rangueil, Toulouse, France
    Rev Mal Respir 20:61-7. 2003
  2. ncbi request reprint [Lung cancer in women and pregnancy: towards a hormonal origin?]
    J Mazieres
    Service de Pneumologie Allergologie, Clinique des Voies Respiratoires, Hopital Larrey, CHU Toulouse, France
    Rev Mal Respir 24:983-97. 2007
  3. doi request reprint Lung cancer patients with HER2 mutations treated with chemotherapy and HER2-targeted drugs: results from the European EUHER2 cohort
    J Mazieres
    Thoracic Oncology Unit, Larrey Hospital, Centre Hospitalier Universitaire de Toulouse, Toulouse University III Paul Sabatier, Toulouse
    Ann Oncol 27:281-6. 2016
  4. doi request reprint Crizotinib therapy for advanced lung adenocarcinoma and a ROS1 rearrangement: results from the EUROS1 cohort
    Julien Mazieres
    Julien Mazières, Damien Rouvière, and Julie D Milia, Hopital Larrey, Centre Hospitalier Universitaire, Université Paul Sabatier Thomas Filleron, Institut Universitaire du Cancer, Toulouse Gérard Zalcman, Centre Hospitalier Universitaire, Universite de Caen Basse Normandie, Caen Pamela Biondani and Benjamin Besse, Gustave Roussy, Villejuif Fabrice Barlesi, Aix Marseille University, Assistance Publique Hopitaux de Marseille, Marseille Hervé Léna, Centre Hospitalier Universitaire, Rennes Isabelle Monnet, Centre Hospitalier Intercommunal de Creteil, Créteil Luc Thiberville, Centre Hospitalier Universitaire, Rouen Nicolas Pecuchet, Institut Curie, Paris, France Lucio Crinò, Medica Azienda Ospedaliera, Perugia Federico Cappuzzo, Istituto Toscano Tumori, Ospedale Civile, Livorno, Italy Anne Marie C Dingemans, Maastricht University Medical Center, Maastricht Egbert F Smit, VU University Medical Center, Amsterdam, Hermann Herder Str. 7
    J Clin Oncol 33:992-9. 2015
  5. ncbi request reprint [Lung cancer in women and pregnancy: towards a hormonal origin?]
    J Mazieres
    Service de Pneumologie Allergologie, Clinique des Voies Respiratoires, Hopital Larrey, CHU Toulouse, France Laboratoire Innovation Thérapeutique et Oncologie Moléculaire, INSERM U563, Institut Claudius Regaud, Toulouse, France Electronic address
    Rev Mal Respir 24:983-97. 2007
  6. doi request reprint Evaluation of EGFR protein expression by immunohistochemistry using H-score and the magnification rule: re-analysis of the SATURN study
    Julien Mazieres
    Service de Pneumologie, Hopital Larrey, Centre Hospitalier Universitaire de Toulouse, Université de Toulouse III Paul Sabatier, Toulouse 31059, France Electronic address
    Lung Cancer 82:231-7. 2013
  7. doi request reprint Specificities of lung adenocarcinoma in women who have never smoked
    Julien Mazieres
    Unité d Oncologie Thoracique, Service de Pneumologie, Hôpital Larrey CHU de Toulouse, Université de Toulouse III Paul Sabatier, Cedex 9, France
    J Thorac Oncol 8:923-9. 2013
  8. doi request reprint Lung cancer that harbors an HER2 mutation: epidemiologic characteristics and therapeutic perspectives
    Julien Mazieres
    Centre Hospitalier Universitaire de Toulouse, Universite de Toulouse III, Toulouse Cedex, France
    J Clin Oncol 31:1997-2003. 2013
  9. ncbi request reprint Limited operation for severe multisegmental bilateral bronchiectasis
    Julien Mazieres
    Department of Pulmonary Diseases, Rangueil Hospital, University of Toulouse, Toulouse, France
    Ann Thorac Surg 75:382-7. 2003
  10. ncbi request reprint Large cell neuroendocrine carcinoma of the lung: pathological study and clinical outcome of 18 resected cases
    Julien Mazieres
    Service de Pneumologie, Hopital Rangueil, 31403 Toulouse Cedex, France
    Lung Cancer 37:287-92. 2002

Detail Information

Publications31

  1. ncbi request reprint [Nodular bronchioloalveolar carcinoma at early stage]
    J Mazieres
    Service de Pneumologie, CHR Rangueil, Toulouse, France
    Rev Mal Respir 20:61-7. 2003
    ..The clinical, pathological and radiological features of 16 consecutive resected cases of early BAC (stage IA) were reviewed...
  2. ncbi request reprint [Lung cancer in women and pregnancy: towards a hormonal origin?]
    J Mazieres
    Service de Pneumologie Allergologie, Clinique des Voies Respiratoires, Hopital Larrey, CHU Toulouse, France
    Rev Mal Respir 24:983-97. 2007
    ..The incidence of lung cancer is increasing dramatically in women in France. It is now the leading cause of cancer deaths among women in the USA and the second in France...
  3. doi request reprint Lung cancer patients with HER2 mutations treated with chemotherapy and HER2-targeted drugs: results from the European EUHER2 cohort
    J Mazieres
    Thoracic Oncology Unit, Larrey Hospital, Centre Hospitalier Universitaire de Toulouse, Toulouse University III Paul Sabatier, Toulouse
    Ann Oncol 27:281-6. 2016
    ..There is, to date, no standard of care for these patients. We thus aim to study the therapeutic outcomes of patients harboring HER2 mutations and establish the efficacy of various drug regimens...
  4. doi request reprint Crizotinib therapy for advanced lung adenocarcinoma and a ROS1 rearrangement: results from the EUROS1 cohort
    Julien Mazieres
    Julien Mazières, Damien Rouvière, and Julie D Milia, Hopital Larrey, Centre Hospitalier Universitaire, Université Paul Sabatier Thomas Filleron, Institut Universitaire du Cancer, Toulouse Gérard Zalcman, Centre Hospitalier Universitaire, Universite de Caen Basse Normandie, Caen Pamela Biondani and Benjamin Besse, Gustave Roussy, Villejuif Fabrice Barlesi, Aix Marseille University, Assistance Publique Hopitaux de Marseille, Marseille Hervé Léna, Centre Hospitalier Universitaire, Rennes Isabelle Monnet, Centre Hospitalier Intercommunal de Creteil, Créteil Luc Thiberville, Centre Hospitalier Universitaire, Rouen Nicolas Pecuchet, Institut Curie, Paris, France Lucio Crinò, Medica Azienda Ospedaliera, Perugia Federico Cappuzzo, Istituto Toscano Tumori, Ospedale Civile, Livorno, Italy Anne Marie C Dingemans, Maastricht University Medical Center, Maastricht Egbert F Smit, VU University Medical Center, Amsterdam, Hermann Herder Str. 7
    J Clin Oncol 33:992-9. 2015
    ..Approximately 1% of lung adenocarcinomas are driven by oncogenic ROS1 rearrangement. Crizotinib is a potent inhibitor of both ROS1 and ALK kinase domains...
  5. ncbi request reprint [Lung cancer in women and pregnancy: towards a hormonal origin?]
    J Mazieres
    Service de Pneumologie Allergologie, Clinique des Voies Respiratoires, Hopital Larrey, CHU Toulouse, France Laboratoire Innovation Thérapeutique et Oncologie Moléculaire, INSERM U563, Institut Claudius Regaud, Toulouse, France Electronic address
    Rev Mal Respir 24:983-97. 2007
    ..The incidence of lung cancer is increasing dramatically in women in France. It is now the leading cause of cancer deaths among women in the USA and the second in France...
  6. doi request reprint Evaluation of EGFR protein expression by immunohistochemistry using H-score and the magnification rule: re-analysis of the SATURN study
    Julien Mazieres
    Service de Pneumologie, Hopital Larrey, Centre Hospitalier Universitaire de Toulouse, Université de Toulouse III Paul Sabatier, Toulouse 31059, France Electronic address
    Lung Cancer 82:231-7. 2013
    ..This novel method was used to reassess samples from SATURN...
  7. doi request reprint Specificities of lung adenocarcinoma in women who have never smoked
    Julien Mazieres
    Unité d Oncologie Thoracique, Service de Pneumologie, Hôpital Larrey CHU de Toulouse, Université de Toulouse III Paul Sabatier, Cedex 9, France
    J Thorac Oncol 8:923-9. 2013
    ..No clear data are available on the high rate of tobacco-independent lung cancer in women. We hypothesize that genetic events or hormonal factors may be partly involved...
  8. doi request reprint Lung cancer that harbors an HER2 mutation: epidemiologic characteristics and therapeutic perspectives
    Julien Mazieres
    Centre Hospitalier Universitaire de Toulouse, Universite de Toulouse III, Toulouse Cedex, France
    J Clin Oncol 31:1997-2003. 2013
    ..HER2 mutations are identified in approximately 2%of non-small-cell lung cancers (NSCLC). There are few data available that describe the clinical course of patients with HER2-mutated NSCLC...
  9. ncbi request reprint Limited operation for severe multisegmental bilateral bronchiectasis
    Julien Mazieres
    Department of Pulmonary Diseases, Rangueil Hospital, University of Toulouse, Toulouse, France
    Ann Thorac Surg 75:382-7. 2003
    ..In our institution, limited operation has been offered to select patients for this indication. We report our data regarding the feasibility and utility of such a procedure...
  10. ncbi request reprint Large cell neuroendocrine carcinoma of the lung: pathological study and clinical outcome of 18 resected cases
    Julien Mazieres
    Service de Pneumologie, Hopital Rangueil, 31403 Toulouse Cedex, France
    Lung Cancer 37:287-92. 2002
    ..This way of relapse underlies the necessity of an efficient chemotherapy in order to improve survival...
  11. pmc Epigenetic regulation of RhoB loss of expression in lung cancer
    Julien Mazieres
    INSERM U563 Département Innovation Thérapeutique et Oncologie Moléculaire, F 31052, Toulouse, France
    BMC Cancer 7:220. 2007
    ..RhoB is down-regulated in most lung cancer cell lines and tumor tissues when compared with their normal counterparts. The mechanism of this loss of expression is not yet deciphered...
  12. doi request reprint [Efficacy and tolerance of bevacizumab in non-small cell lung cancer: preliminary report]
    J Mazieres
    Service de Pneumologie, Hopital Larrey, CHU de Toulouse, chemin de Pouvourville, 31059 Toulouse, France
    Rev Pneumol Clin 64:166-72. 2008
    ..Due its original mechanism of action, bevacizumab has a very specific safety profile and radiological response patterns...
  13. ncbi request reprint [Radiofrequency ablation of primary lung cancer: a single centre experience]
    N Leveque
    Service de Pneumologie, Clinique des Voies Respiratoires, Hopital Larrey, CHU de Toulouse, France
    Rev Mal Respir 26:924-9. 2009
    ..This procedure is already used in liver and renal cancers and metastases, and is now being evaluated in primary and secondary lung tumors...
  14. doi request reprint Multicenter observational study of erlotinib therapy (OBSTAR) for non small-cell lung cancer: a GFPC study
    A Vergnenegre
    Service de Pneumologie, Hopital du Cluzeau, et Unité de Recherche Clinique et Biostatistique, CHU Limoges, France
    Lung Cancer 74:264-7. 2011
    ..Erlotinib therapy for non small-cell lung cancer (NSCLC) has mainly been evaluated in randomized trials...
  15. ncbi request reprint Diagnostic value of bronchoscopy, CT and transbronchial biopsies in diffuse pulmonary lymphangiomatosis: case report and review of the literature
    L El Hajj
    Department of Radiology, University of Toulouse, avenue Jean Poulhes, 31403 Toulouse, France
    Clin Radiol 60:921-5. 2005
    ..The diagnosis can be made by transbronchial biopsy without performing open lung biopsy which was, until now, considered necessary for diagnosis...
  16. ncbi request reprint [Surgical management and outcomes of lung cancer in women - results from the Epithor database]
    L Brouchet
    Service de Chirurgie Thoracique, Clinique des Voies Respiratoires, Hôpital Rangueil Larrey, CHU de Toulouse, France
    Rev Mal Respir 24:877-82. 2007
    ..Rates of lung cancer in women have been increasing continually for several years. The basic surgical management of this condition is the same in both sexes but a number of differences are apparent...
  17. ncbi request reprint [Thermal ablation: tolerance and efficacy in a population mostly composed of primary lung cancers]
    F Chamming's
    Service de radiologie générale CHU Rangueil, avenue du Professeur Jean Poulhes, Toulouse Cedex, France
    J Radiol 91:885-94. 2010
    ..The purpose of this study was to determine the tolerability and efficacy of this treatment in 29 consecutive patients, most of which with primary lung cancers, managed in our center...
  18. doi request reprint [An analysis of treatment delays of thoracic cancers: a prospective study]
    N Leveque
    Unité d oncologie cervico thoracique clinique des voies, Service de Pneumologie, Universite Paul Sabatier, Hopital Larrey, CHU de Toulouse, chemin de Pouvourville, 31059 Toulouse Cedex, France
    Rev Mal Respir 31:208-13. 2014
    ..Lung cancer is the main cause of cancer death in France. The diagnosis is often late and the delay between the onset of symptoms and management is considered an aggravating factor...
  19. ncbi request reprint Expression of TTF-1 and cytokeratins in primary and secondary epithelial lung tumours: correlation with histological type and grade
    V Jerome Marson
    Service d Anatomie et Cytologie Pathologiques, Hopital Purpan, Toulouse, France
    Histopathology 45:125-34. 2004
    ..To assess cytokeratin (CK) and thyroid transcription factor (TTF)-1 expression in primary epithelial lung tumours by comparison with non-pulmonary carcinomas and to correlate it with their histological type and grade...
  20. ncbi request reprint [Stenting for superior vena cava obstruction associated with lung cancer: monocentric study]
    M C Pierre
    Service de Pneumologie Allergologie, Clinique des Voies Respiratoires, Hopital Larrey, Toulouse, France
    Rev Mal Respir 26:744-50. 2009
    ..Superior vena cava obstruction is an urgent complication of lung cancer. Superior vena cava stent insertion can be considered to provide rapid relief of the symptoms...
  21. doi request reprint Radiofrequency ablation for non-small-cell lung cancer in a single-lung patient: case report and review of the literature
    A Modesto
    Radiation Oncology Department, Institut Claudius Regaud, 20 24 rue du Pont saint Pierre, 31000 Toulouse, France
    Lung Cancer 80:341-3. 2013
    ..Patients presenting with a lung tumor that occurs in a single lung due to a prior pneumonectomy are difficult to manage with a curative intent due to the risk of complications after local treatment...
  22. doi request reprint [COPD and lung cancer: epidemiological and biological links]
    G Prevot
    Service de Pneumologie, Clinique des Voies Respiratoires, Hopital Larrey, CHU Toulouse, Toulouse, France
    Rev Mal Respir 29:545-56. 2012
    ..Consequently, improvements in the management of these two diseases will involve a more intensive investigation of their physiopathology, and require a closer collaboration between research centres and clinical units...
  23. doi request reprint [Incidence and characteristics of bronchial colonisation in patient with lung cancer: a retrospective study of 388 cases]
    S Laroumagne
    Service de Pneumologie, Clinique des Voies Respiratoires, Hopital Larrey, CHU de Toulouse, 24 chemin de Pouvourville, Toulouse Cedex 09, France
    Rev Mal Respir 28:328-35. 2011
    ..These colonisations could influence patient therapeutic management and prognosis. The aim of our study is refine incidence and nature of bronchial colonisations in patients presenting with lung cancer...
  24. ncbi request reprint [Sport and atopy]
    A Didier
    Service de Pneumologie et d Allergologie, CHR Rangueil, Toulouse, France
    Rev Mal Respir 20:727-34. 2003
    ..The atopic diseases, asthma, allergic rhinitis and atopic dermatitis, are common in children, adolescents and young adults. They may have important consequences on physical exercise, especially asthma...
  25. ncbi request reprint [Pulmonary embolism in patients using estrogen-progestagen contraceptives]
    D Lauque
    Services de Médecine Interne, Hopital Purpan, Toulouse
    Presse Med 27:1566-9. 1998
    ..We examined the clinical features, risk factors and outcome of pulmonary embolism in this context...
  26. doi request reprint [An unusual mediastinal mass]
    E Bousquet
    Service de Pneumologie, Unité d Oncologie Cervico Thoracique, Hopital Larrey, Universite Paul Sabatier, CHU de Toulouse, chemin de Pouvourville, 31059 Toulouse Cedex, France Electronic address
    Rev Mal Respir 31:624-7. 2014
    ..Primary mediastinal tumors are rare diseases including a broad spectrum of pathologies ranging from the well-known, such as lymphoma, thymoma or germ-line tumors to some very unusual presentations...
  27. ncbi request reprint [Acute bronchial constriction in a non-asthmatic patient provoked by Airbag(R) activation]
    J Mazieres
    Service de Pneumologie, CHR Rangueil, Toulouse, France
    Rev Mal Respir 19:537-8. 2002
  28. doi request reprint [A brief overview of a lung cancer biomarker: thymidylate synthase]
    I Rouquette
    Laboratoire d Anatomie Pathologique, Hopital Rangueil, CHU de Toulouse, 31000 Toulouse, France
    Rev Mal Respir 28:773-7. 2011
    ..This may help in defining the best therapeutic strategy...
  29. doi request reprint Management of malignant pleural mesothelioma: a French multicenter retrospective study (GFPC 0802 study)
    C Raynaud
    Service de Pneumologie, CH Argenteuil, Argenteuil, France
    BMC Cancer 15:857. 2015
    ..Malignant pleural mesothelioma (MPM) is a rare disease with poor prognosis in spite of significant improvement in survival, due to new chemotherapy regimens. We describe here patients' profiles and management in daily practice in France...
  30. doi request reprint [New targets and new drugs in thoracic oncology]
    D Rouvière
    Service de Pneumologie, Hopital Larrey, CHU de Toulouse, Universite Paul Sabatier, 31000 Toulouse, France
    Rev Mal Respir 32:867-76. 2015
    ..Some of these molecules are now approved as therapies, others are currently undergoing testing in clinical trials. We here present a review of novel targeted agents for lung cancer. ..
  31. ncbi request reprint [How to treat the relapse of NSCLC after surgery and chemotherapy? IFTC 0702 randomized phase III study]
    D Moro-Sibilot
    PMAC Clinique de Pneumologie, CHU de Grenoble, France
    Rev Mal Respir 25:91-6. 2008
    ..The current study has been designed to compare the classical mono chemotherapy docetaxel with a docetaxel cisplatin doublet...